Stephens Inc’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $201K | Sell |
2,425
-585
| -19% | -$48.5K | ﹤0.01% | 1173 |
|
2025
Q1 | $244K | Buy |
3,010
+30
| +1% | +$2.43K | ﹤0.01% | 1070 |
|
2024
Q4 | $268K | Hold |
2,980
| – | – | ﹤0.01% | 1062 |
|
2024
Q3 | $294K | Sell |
2,980
-2,940
| -50% | -$290K | ﹤0.01% | 1036 |
|
2024
Q2 | $549K | Sell |
5,920
-465
| -7% | -$43.1K | 0.01% | 752 |
|
2024
Q1 | $606K | Sell |
6,385
-35
| -0.5% | -$3.32K | 0.01% | 735 |
|
2023
Q4 | $573K | Sell |
6,420
-5,692
| -47% | -$508K | 0.01% | 698 |
|
2023
Q3 | $884K | Sell |
12,112
-1,465
| -11% | -$107K | 0.02% | 549 |
|
2023
Q2 | $1.13M | Sell |
13,577
-8,895
| -40% | -$740K | 0.02% | 520 |
|
2023
Q1 | $1.71M | Buy |
22,472
+1,606
| +8% | +$122K | 0.03% | 422 |
|
2022
Q4 | $1.73M | Sell |
20,866
-49,687
| -70% | -$4.12M | 0.04% | 401 |
|
2022
Q3 | $5.6M | Buy |
70,553
+56,652
| +408% | +$4.49M | 0.12% | 189 |
|
2022
Q2 | $1.03M | Buy |
+13,901
| New | +$1.03M | 0.02% | 514 |
|
2022
Q1 | – | Sell |
-8,612
| Closed | -$964K | – | 1406 |
|
2021
Q4 | $964K | Sell |
8,612
-1,925
| -18% | -$215K | 0.01% | 644 |
|
2021
Q3 | $1.33M | Sell |
10,537
-325
| -3% | -$40.9K | 0.02% | 565 |
|
2021
Q2 | $1.47M | Sell |
10,862
-45
| -0.4% | -$6.09K | 0.02% | 552 |
|
2021
Q1 | $1.48M | Sell |
10,907
-1,495
| -12% | -$203K | 0.02% | 520 |
|
2020
Q4 | $1.75M | Buy |
12,402
+33
| +0.3% | +$4.65K | 0.03% | 456 |
|
2020
Q3 | $1.38M | Buy |
12,369
+45
| +0.4% | +$5.01K | 0.03% | 463 |
|
2020
Q2 | $1.38M | Buy |
12,324
+450
| +4% | +$50.4K | 0.03% | 443 |
|
2020
Q1 | $920K | Buy |
11,874
+646
| +6% | +$50.1K | 0.02% | 488 |
|
2019
Q4 | $1.07M | Buy |
11,228
+50
| +0.4% | +$4.76K | 0.02% | 536 |
|
2019
Q3 | $852K | Sell |
11,178
-1,007
| -8% | -$76.8K | 0.02% | 599 |
|
2019
Q2 | $1.07M | Buy |
12,185
+268
| +2% | +$23.5K | 0.02% | 560 |
|
2019
Q1 | $1.08M | Buy |
11,917
+1,800
| +18% | +$163K | 0.03% | 550 |
|
2018
Q4 | $726K | Buy |
+10,117
| New | +$726K | 0.02% | 597 |
|